Symposium introduction: Metabolic syndrome and the onset of cancer

American Journal of Clinical Nutrition

Volumn 86, Issue 3, 2007, Pages

  Zhou, Jin Rong ^a   Blackburn, George L ^a   Walker, W Allan ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Cancer; Epidemiology; Metabolic syndrome; Nutrition; Obesity; Symposium

Indexed keywords

COMORBIDITY; EDITORIAL; HUMAN; METABOLIC SYNDROME X; MORTALITY; NEOPLASM; RISK FACTOR;

COMORBIDITY; HUMANS; METABOLIC SYNDROME X; NEOPLASMS; RISK FACTORS;

EID: 40349116042     PISSN: 00029165     EISSN: 19383207     Source Type: Journal    
DOI: 10.1093/ajcn/86.3.817s     Document Type: Conference Paper

References (29)

1. Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 1988;37:1595-607. (Pubitemid 19004941)
2. Stoll BA. Western nutrition and the insulin resistance syndrome: a link to breast cancer. Eur J Clin Nutr 1999;53:83-7. (Pubitemid 29082524)
3. Calle EE, Kaaks R. Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer 2004;4:579-91. (Pubitemid 39025053)
4. Jee SH, Ohrr H, Sull JW, Yun JE, Ji M, Samet JM. Fasting serum glucose level and cancer risk in Korean men and women. JAMA 2005;293:194-202. (Pubitemid 40095870)
5. Inoue M, Iwasaki M, Otani T, Sasazuki S, Noda M, Tsugane S. Diabetes mellitus and the risk of cancer: results from a large-scale population-based cohort study in Japan. Arch Intern Med 2006;166:1871-7. (Pubitemid 44455170)
6. Chiu HM, Lin JT, Shun CT, et al. Association of metabolic syndrome with proximal and synchronous colorectal neoplasm. Clin Gastroenterol Hepatol 2007;5:221-9.
7. Ahmed RL, Schmitz KH, Anderson KE, Rosamond WD, Folsom AR. The metabolic syndrome and risk of incident colorectal cancer. Cancer 2006;107:28-36. (Pubitemid 43941640)
8. Laukkanen JA, Laaksonen DE, Niskanen L, Pukkala E, Hakkarainen A, Salonen JT. Metabolic syndrome and the risk of prostate cancer in Finnish men: a population-based study. Cancer Epidemiol Biomarkers Prev 2004;13:1646-50. (Pubitemid 39331887)
9. Lund Haheim L, Wisloff TF, Holme I, Nafstad P. Metabolic syndrome predicts prostate cancer in a cohort of middle-aged Norwegian men followed for 27 years. Am J Epidemiol 2006;164:769-74. (Pubitemid 44522081)
10. Hammarsten J, Hogstedt B. Hyperinsulinaemia: a prospective risk factor for lethal clinical prostate cancer. Eur J Cancer 2005;41:2887-95. (Pubitemid 41713128)
11. Pasanisi P, Berrino F, De Petris M, Venturelli E, Mastroianni A, Panico S. Metabolic syndrome as a prognostic factor for breast cancer recurrences. Int J Cancer 2006;119:236-8.
12. Xue F, Michels KB. Diabetes, metabolic syndrome, and breast cancer: a review of the current evidence. Am J Clin Nutr 2007;86(suppl):823S-35S.
13. Giovannucci E. Metabolic syndrome, hyperinsulinemia, and colon cancer: a review. Am J Clin Nutr 2007;86(suppl):836S-42S.
14. Hsing AW, Sakoda LC, Chua SC. Obesity, metabolic syndrome, and prostate cancer. Am J Clin Nutr 2007;86(suppl):843S-57S.
15. Pollak MN. Insulin, insulin-like growth factors, insulin resistance, and neoplasia. Am J Clin Nutr 2007;86(suppl):820S-2S.
16. Kadowaki T, Yamauchi T. Adiponectin and adiponectin receptors. Endocr Rev 2005;26:439-51. (Pubitemid 40686653)
17. Yamauchi T, Kamon J, Waki H, et al. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 2001;7:941-6. (Pubitemid 32756432)
18. Barb D, Williams CJ, Neuwirth AK, Mantzoros CS. Adiponectin in relation to malignancies: a review of existing basic research and clinic evidence. Am J Clin Nutr 2007;86(suppl):858S-66S.
19. Shulman GI. Cellular mechanisms of insulin resistance. J Clin Invest 2000;106:171-6. (Pubitemid 30483118)
20. Reaven GM, Hollenbeck C, Jeng C-Y, Wu MS, Chen Y-D. Measurement of plasma glucose, free fatty acid, lactate, and insulin for 24 h in patients with NIDDM. Diabetes 1988;37:1020-4. (Pubitemid 19033579)
21. Frayne KN. Insulin resistance and lipid metabolism. Curr Opin Lipidol 1993;4:197-204.
22. Boden G, Chen X, Ruiz J, White JV, Rosetti L. Mechanism of fatty acid induced inhibition of glucose uptake. J Clin Invest 1994;93:2438-46. (Pubitemid 24177157)
23. Hsu IR, Kim SP, Kabir M, Bergman RN. Metabolic syndrome, hyper-insulinemia, and cancer. Am J Clin Nutr 2007;86(suppl):867S-71S.
24. Ross SA, Milner JA. Epigenetic modulation and cancer: effect of metabolic syndrome? Am J Clin Nutr 2007;86(suppl):872S-7S.
25. Zhou J-R, Yu L, Zhong Y, Blackburn GL. Soy phytochemicals and tea bioactive components synergistically inhibit androgen-sensitive human prostate tumors in mice. J Nutr 2003;133:516-21. (Pubitemid 36172909)
26. Zhou J-R, Yu L, Mai Z, Blackburn GL. Combined inhibition of estrogen-dependent human breast carcinoma by soy and tea bioactive components in mice. Int J Cancer 2004;108:8-14. (Pubitemid 37444437)
27. Zhou J-R, Li L, Pan W. Dietary soy and tea combinations for prevention of breast and prostate cancers by targeting metabolic syndrome elements in mice. Am J Clin Nutr 2007;86(suppl):882S-8S.
28. Barnard RJ. Prostate cancer prevention by nutritional means to alleviate metabolic syndrome. Am J Clin Nutr 2007;86(suppl):889S-93S.
29. Blackburn GL, Wang KA. Dietary fat reduction and breast cancer outcome: results from the Women's Intervention Nutrition Study (WINS). Am J Clin Nutr 2007;86(suppl):878S-81S.